Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sclerotherapy of hydroceles and spermatoceles with Aethoxysklerol vs Aethoxysklerol + ethanol
2022-502284-38-00Phase 3Authorised
- Sponsor
- Region Jämtland Härjedalen
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of 10XB101 in hydrocele and spermatocele (2 arms), sponsored by Region Jämtland Härjedalen. Primary endpoints: Symptoms from the treated side 3 months from treatment and Pain during treatment. Planned start Nov 2024; status: authorised.
02
Drugs
10XB101
03
Conditions
hydrocelespermatocele
Beyond the preview
Go deeper on 2022-502284-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502284-38-00.